MedTrace Logo

A Psychomotor Group Intervention for Young Adults With Anxiety Symptoms

NCT07681765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-07-02

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a psychomotor (a body-oriented therapy) group intervention can be feasibly delivered to a group of young adults (age 18-35) with anxiety symptoms within a higher educational setting.

The main questions it aims to answer are:

* Is it possible to recruit and retain participants in this intervention?
* Is the intervention acceptable and tolerable to participants?
* Do participants complete the planned sessions and assessments?

Participants will:

* Attend one weekly group session over ten consecutive weeks
* Participate in active and contemplative body-based exercises
* Complete questionnaires about their mental health and interviews about their experiences of participating

Conditions

  • Anxiety
  • Stress and Anxiety
  • Interoceptive Awareness
  • Interoception
  • Feasibility Studies
  • The Focus of the Study is Feasibility Measures Such as Recruitment, Retention, Fidelity, and Acceptability

Interventions

BEHAVIORAL

Ten weekly psychomotor therapy group sessions

Ten weekly sessions of a psychomotor therapy group program. Session duration: 2½ hours. Group size: 12 participants. Sessions include psychoeducational content and body-oriented exercises such as breathing exercises, relaxation exercises, body scans, or grounding exercises.

Sponsors & Collaborators

  • VIA University College

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
34 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-12
Primary Completion
2025-12-18
Completion
2025-12-18

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07681765 on ClinicalTrials.gov